AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?
Published . Updated .
This report is about the broad US market.
Directly affected
- ANAB Anaptysbio-3.3% 6d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-1.7% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story.
- QQQ Invesco QQQ+0.4% 17d
Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that AnaptysBio belongs to, so it often moves with news about it.
- LLY Eli Lilly and+12.6% 30d
Eli Lilly and is a peer of AnaptysBio in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson-0.2% 30d
Johnson & Johnson is a peer of AnaptysBio in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+9.0% 30d
AbbVie is a peer of AnaptysBio in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck-2.9% 14d
Merck is a peer of AnaptysBio in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories-0.6% 30d
Abbott Laboratories is a peer of AnaptysBio in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ANAB | -6.80% | -1.38% | base | +0.80% | after close | after close | after close |
| DIANo price data for this ticker | — | — | — | — | — | — | — |
| QQQ | +0.72% | -1.06% | base | +0.71% | after close | after close | after close |
| XLVNo price data for this ticker | — | — | — | — | — | — | — |
| LLYNo price data for this ticker | — | — | — | — | — | — | — |
| JNJNo price data for this ticker | — | — | — | — | — | — | — |
| ABBVNo price data for this ticker | — | — | — | — | — | — | — |
| MRKNo price data for this ticker | — | — | — | — | — | — | — |
| ABTNo price data for this ticker | — | — | — | — | — | — | — |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy? Yahoo Finance
Source: Yahoo Finance
How far Spdr Dow Jones Industrial Average Etf Trust (DIA) has moved since 27 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| ANAB | that day | +0.80% | still updating |
| ANAB | three days earlier | -1.38% | final price |
| ANAB | five days earlier | -6.80% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | that day | +0.71% | still updating |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | -1.06% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +0.72% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 32 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 49 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 43 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought AbbVie (ABBV), worth $50,001 - $100,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 33 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 69 days before publication. Filed 9 Sep 2026. View the filing.
- Donald J Trump, an executive branch official, sold Merck (MRK), worth $250,001 - $500,000 on 31 Jul 2026. That is 88 days before publication. Filed 22 Sep 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 39 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 53 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Spdr Dow Jones Industrial Average Etf Trust (DIA)
Companies carried with this story
- DIA Spdr Dow Jones Industrial Average Etf Trust
For “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” Spdr Dow Jones Industrial Average Etf Trust (DIA) is linked, with no stored direction, medium confidence. Reason on file: SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- QQQ Invesco Qqq Trust, Series 1
In “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- IWM Ishares Tr
In “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” Ishares Tr (IWM) is linked, with no stored direction, medium confidence. Reason on file: iShares Russell 2000 ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- RSP Invesco Exchange Traded Fd T
For “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” Invesco Exchange Traded Fd T (RSP) is linked, with no stored direction, medium confidence. Reason on file: Invesco S&P 500 Equal Weight ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
- VTI Vanguard Index Fds
For “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” Vanguard Index Fds (VTI) is linked, with no stored direction, medium confidence. Reason on file: Vanguard Total Stock Market ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
Spdr Dow Jones Industrial Average Etf Trust (DIA)
Spdr Dow Jones Industrial Average Etf Trust (DIA) is the company in “AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?,” the 27 Oct 2026 this story story.
Spdr Dow Jones Industrial Average Etf Trust (DIA) is on the page because SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
A second company, Invesco Qqq Trust, Series 1 (QQQ), is listed for a different reason: Invesco QQQ: it is a broad US stock-market fund. Linked by “earnings estimates” (the broad US market) in this story
Price levels for Spdr Dow Jones Industrial Average Etf Trust (DIA)
DIA traded between 504.92 and 522.62 across 20 sessions. The latest close on file is 515.65. IWM traded between 269.88 and 284.63 across 20 sessions. The latest close on file is 276.95. QQQ traded between 701.18 and 762.84 across 17 sessions. The latest close on file is 712.11.
How strong the case is around Spdr Dow Jones Industrial Average Etf Trust (DIA)
40 out of 100Price not final
“AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Should You Buy?” scores 40 out of 100. The score uses 1 sources, and 5 linked companies. The price is not final yet.